添加链接
link管理
链接快照平台
  • 输入网页链接,自动生成快照
  • 标签化管理网页链接
drughunter.com
< 1 minute read
Sep. 12, 2024

Drug Discovery Books

Drug Hunter Team
Loading...
Join Drug Hunter to access scientifically rich molecule case studies, patent highlights, and structure search to spark research ideas in minutes. Get in touch by filling out the form below and a Drug Team member will be in touch with you and your team shortly.
Loading...

Other resources you may be interested in

STAT3 Target Review: Small Molecule Inhibitors

STAT3 hyperactivity is implicated in over 70% of human cancers. Despite three decades of research spanning small molecules, nucleotides, and heterobifunctional degraders, no STAT3-targeted therapy has achieved regulatory approval. Of the 11 small molecule compounds that have entered clinical trials, only four remain in active investigation. This review explores the successes and setbacks in the ongoing pursuit of the first STAT3-targeted oncology drug. Read on for a deep dive into these efforts and the evolving landscape of small molecule STAT3 inhibitor drug discovery.